Home › Funds › Trustees of Columbia University in the City of New York › TARS
Trustees of Columbia University in the City of New York position in TARS
TARSUS PHARMACEUTICALS INC · Health Care
Trustees of Columbia University in the City of New York reported holding 44,144 shares of TARS (TARSUS PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$3.5M, representing 0.57% of its reported portfolio and ranking #2 among its reported holdings. Trustees of Columbia University in the City of New York first reported this position in Q3 2026.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Trustees of Columbia University in the City of New York's TARS position evolved
Trustees of Columbia University in the City of New York first disclosed a stake in TARS in Q3 2026 at 44,144 shares (US$3.5M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 44.14K | $3.47M | New |
About TARS and 13F data
TARS (TARSUS PHARMACEUTICALS INC) is a Health Care company. 43 other funds we track also report a position in TARS — the largest reported positions include Deep Track Capital, LP (US$299.3M), RTW INVESTMENTS, LP (US$273.9M), Paradigm Biocapital Advisors LP (US$180.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding TARS
- Deep Track Capital, LP 3.81M sh · $299.25M · Q3 2026
- RTW INVESTMENTS, LP 3.48M sh · $273.88M · Q3 2026
- Paradigm Biocapital Advisors LP 2.30M sh · $180.91M · Q3 2026
- TANG CAPITAL MANAGEMENT LLC 1.57M sh · $98.71M · Q2 2026
- Bain Capital Life Sciences Investors, LLC 1.10M sh · $86.17M · Q3 2026
- Vestal Point Capital, LP 1.05M sh · $66.09M · Q2 2026
- Frazier Life Sciences Management, L.P. 728.64K sh · $45.86M · Q2 2026
- TCG Crossover Management, LLC 388.16K sh · $30.51M · Q3 2026
- Rock Springs Capital Management LP 285.12K sh · $22.41M · Q3 2026
More on Trustees of Columbia University in the City of New York
FAQ
How long has Trustees of Columbia University in the City of New York held TARS?
Trustees of Columbia University in the City of New York has disclosed TARS holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is Trustees of Columbia University in the City of New York's current position in TARS?
As of Q3 2026, Trustees of Columbia University in the City of New York holds 44.14K shares of TARS (TARSUS PHARMACEUTICALS INC), valued at $3.47M, representing 0.57% of its reported portfolio and ranking #2.
Has Trustees of Columbia University in the City of New York been buying or selling TARS?
In the latest 13F filing (Q3 2026), Trustees of Columbia University in the City of New York newly opened its position in TARS.
Which other funds hold TARS?
Other major institutional holders of TARS include Deep Track Capital, LP, RTW INVESTMENTS, LP, Paradigm Biocapital Advisors LP, among 43 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.